Dr Reddy’s Archives - Express Pharma

Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir

Dr Reddy’s receives positive CHMP opinion for biosimilar Rituximab candidate in European markets

Alvotech and Dr Reddy’s collaborate on biosimilar AVT03

Industry growth weakens sharply in Mar’24

Dr Reddy’s rolls out Nerivio, drug-free non-invasive migraine management device, in India

USFDA completes GMP inspection of Dr Reddy’s Hyderabad API manufacturing facility

Dr Reddy’s ropes in Sonu Sood as brand ambassador for Rebalanz VITORS

Express Pharma-Nutrify Today Boardroom series to be launched this February

Dr Reddy’s Lab Q3 results: Consolidated net profit up 77 per cent at Rs 1,247 crore

Dr Reddy’s completes clinical studies of rituximab biosimilar for filing in US and Europe